Last10K.com

Radiation Therapy Services Holdings, Inc. (RTSX) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2012

21St Century Oncology Holdings, Inc.

CIK: 1503518 Ticker: RTSX

Exhibit 99.1

 

 

RADIATION THERAPY SERVICES HOLDINGS, INC.

 

Contact:

Bryan J. Carey

Chief Financial Officer

239-931-7285

BCarey@rtsx.com

 

Investors:

Amy Glynn / Nick Laudico

The Ruth Group

646-536-7023 / 7030

aglynn@theruthgroup.com

nlaudico@theruthgroup.com

 

RADIATION THERAPY SERVICES REPORTS FOURTH QUARTER AND FULL YEAR 2012 FINANCIAL RESULTS

 

Fourth Quarter 2012 Highlights:

·                  Total company pro forma revenues of $168.8 million, equaling last year despite lower reimbursement rates and decreased prostate volumes

·                  Domestic same practice treatments per day decreased 1.9% as declines in prostate cases were partially offset by growth of other diagnoses

·                  Pro Forma Adjusted EBITDA of $24.2 million, includes absorption of $5.5 million revenue reduction from declines in prostate cancer treatments

·                  Executed in November 2012 a Value Added Services agreement with Park Ridge Health in North Carolina

·                  International cases increased 4.8%

·                  Declines in prostate cancer treatments decelerating since January 1

 

Full Year 2012 Highlights:

·                  Total company pro forma revenues of $700.4 million, up 5.1% year-over-year

·                  Domestic same practice treatments per day increased 2.0%

·                  International cases increased 10.5%

·                  Pro Forma Adjusted EBITDA of $104.7 million, includes absorption of $15.8 million revenue impact from declines in prostate cancer treatments

·                  Successfully implemented the North Broward Health Value Added Services agreement

 

FORT MYERS, FL, March 13, 2013 —

Radiation Therapy Services Holdings, Inc (“Radiation Therapy” or “the Company”), a leading operator of radiation therapy centers, announced today its financial results for the fourth quarter and full year ended December 31, 2012.

 

Dr. Daniel Dosoretz, President and Chief Executive Officer, commented, “The fourth quarter of 2012 was challenging, with greater than expected declines in the treatment of prostate cancer.  While we expect these declines to persist through the first half of 2013, we believe the worst is behind us, as we have seen the declines in treatment volumes decelerating in the first two months of 2013.  Importantly, we implemented a number of initiatives in 2012 that will strengthen our leadership

 


The following information was filed by 21St Century Oncology Holdings, Inc. (RTSX) on Wednesday, March 13, 2013 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate 21St Century Oncology Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by 21St Century Oncology Holdings, Inc..

Continue

Assess how 21St Century Oncology Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

21St Century Oncology Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Cash Flows (parenthetical)
Consolidated Statements Of Comprehensive Loss
Acquisitions
Acquisitions (details 2)
Acquisitions (details 3)
Acquisitions (details 4)
Acquisitions (details 5)
Acquisitions (details)
Acquisitions (tables)
Capital Lease Arrangements
Capital Lease Arrangements (details)
Capital Lease Arrangements (tables)
Commitments And Contingencies
Commitments And Contingencies (details 2)
Commitments And Contingencies (details 3)
Commitments And Contingencies (details)
Commitments And Contingencies (tables)
Consolidated Statements Of Changes In Equity
Equity Investments In Joint Ventures
Equity Investments In Joint Ventures (details 2)
Equity Investments In Joint Ventures (details)
Equity Investments In Joint Ventures (tables)
Fair Value Of Financial Instruments
Fair Value Of Financial Instruments (details 2)
Fair Value Of Financial Instruments (details)
Fair Value Of Financial Instruments (tables)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (details 2)
Goodwill And Intangible Assets (details 3)
Goodwill And Intangible Assets (details 4)
Goodwill And Intangible Assets (details 5)
Goodwill And Intangible Assets (details)
Goodwill And Intangible Assets (tables)
Income Taxes
Income Taxes (details 2)
Income Taxes (details 3)
Income Taxes (details 4)
Income Taxes (details)
Income Taxes (tables)
Long-term Debt
Long-term Debt (details 2)
Long-term Debt (details 3)
Long-term Debt (details 4)
Long-term Debt (details)
Long-term Debt (tables)
Organization And Basis Of Presentation
Other Income And Loss
Other Income And Loss (details 2)
Other Income And Loss (details 3)
Other Income And Loss (details 4)
Other Income And Loss (details)
Property And Equipment
Property And Equipment (details)
Property And Equipment (tables)
Real Estate Subject To Finance Obligation
Real Estate Subject To Finance Obligation (details)
Real Estate Subject To Finance Obligation (tables)
Reconciliation Of Total Equity And Noncontrolling Interests
Reconciliation Of Total Equity And Noncontrolling Interests (details)
Reconciliation Of Total Equity And Noncontrolling Interests (tables)
Related Party Transactions (details)
Related-party Transactions
Retirement And Deferred Compensation Plans
Retirement And Deferred Compensation Plans (details)
Segment And Geographic Information
Segment And Geographic Information (details 2)
Segment And Geographic Information (details)
Segment And Geographic Information (tables)
Stock Option Plan And Restricted Stock Grants
Stock Option Plan And Restricted Stock Grants (details)
Stock Option Plan And Restricted Stock Grants (tables)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (details 10)
Summary Of Significant Accounting Policies (details 11)
Summary Of Significant Accounting Policies (details 2)
Summary Of Significant Accounting Policies (details 3)
Summary Of Significant Accounting Policies (details 4)
Summary Of Significant Accounting Policies (details 5)
Summary Of Significant Accounting Policies (details 6)
Summary Of Significant Accounting Policies (details 7)
Summary Of Significant Accounting Policies (details 8)
Summary Of Significant Accounting Policies (details 9)
Summary Of Significant Accounting Policies (details)
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (tables)
Supplemental Consolidating Financial Information
Supplemental Consolidating Financial Information (details 2)
Supplemental Consolidating Financial Information (details 3)
Supplemental Consolidating Financial Information (details)
Supplemental Consolidating Financial Information (tables)
Unaudited Quarterly Financial Information
Unaudited Quarterly Financial Information (details)
Unaudited Quarterly Financial Information (tables)
Ticker: RTSX
CIK: 1503518
Form Type: 10-K Annual Report
Accession Number: 0001047469-13-003556
Submitted to the SEC: Thu Mar 28 2013 1:32:44 PM EST
Accepted by the SEC: Thu Mar 28 2013
Period: Monday, December 31, 2012
Industry: Offices And Clinics Of Doctors Of Medicine

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/rtsx/0001047469-13-003556.htm